Cuttsy+Cuttsy launches R:SQD – a new way to predict and improve trial success
November 27, 2025 | Campaign planning, Protocol consulting, R:SQD, Study rescue, clinical trials
Cuttsy+Cuttsy has launched R:SQD, an innovative recruitment and retention success scoring tool that helps clinical trial sponsors predict, measure, and improve participant engagement and trial outcomes.
R:SQD, a groundbreaking recruitment and retention success scoring tool that gives clinical trial sponsors the evidence, insight, and confidence to design and deliver truly participant-centred studies, has launched today.
By blending trial data with patient insights, R:SQD delivers a clear, evidence-based score showing how ready a trial is to attract, recruit, and retain participants, as well as providing tailored recommendations to strengthen engagement and protect trial outcomes.
A new kind of trial health check
R:SQD provides a rapid, evidence-based assessment of how participant-ready a study really is. Its unique scoring system reveals the barriers that may be limiting recruitment or driving dropouts, while expert-driven recommendations help sponsors act early, remove friction, and build trust with participants.
“When recruitment slows or retention drops, it can be hard to see what’s really holding a trial back,” said Stacey Davidson, Head of Strategy and Content at Cuttsy+Cuttsy. “R:SQD cuts through the noise, combining data and empathy to deliver clarity, confidence, and practical next steps. It’s about turning insight into action – helping today’s trials become tomorrow’s breakthroughs.”
Supporting every stage of the trial journey
R:SQD is designed to add value across the full trial lifecycle, whether teams are rescuing an underperforming study, planning a launch, or designing a protocol.
- Study rescue: When a trial is struggling, R:SQD delivers a rapid health check and recovery plan, pinpointing participant-experience fail points and guiding sponsors to regain momentum, protect timelines, and rebuild engagement.
- Campaign planning: Ahead of launch, R:SQD predicts how ready a study is to support participants from day 1. Its readiness score and activation blueprint help leaders allocate resources effectively, identify risks early, and ensure every new trial starts strong.
- Protocol consulting: By reviewing draft protocols through a participant lens, R:SQD highlights where complexity or burden could affect enrolment and retention, helping teams design trials that are not only scientifically robust but also patient-ready and practical in the real world.
Turning data into difference
Unlike traditional analytics platforms, R:SQD blends quantitative insight with human understanding. Its tailored recommendations provide clear, evidence-based actions that make trials more inclusive, efficient, and participant friendly.
“R:SQD reflects our belief that people should be at the heart of every clinical trial,” said Mathew Cutts, Co-Founder and Director of Cuttsy+Cuttsy. “By giving sponsors the tools to see, understand, and address the real barriers to participation, we can help create studies that deliver better experiences and better results.”
Ready to give your trial a health check?
R:SQD is now available to pharmaceutical companies, CROs, and research organisations seeking to strengthen recruitment, retention, and participant engagement strategies.
Discover how R:SQD can put your trial on track for success. Talk to our team.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Clinical trial considerations: Why digital matters…
Digital technology in healthcare is rapidly evolving. In this blog we delve into how digital solutions can help improve patient experience within clinical trials.
Clinical trials explained: Why imagery matters…
Recruiting patients for clinical trials is one of pharma's greatest challenges. Imagery is a great way to connect with people on an emotional level and forms a big part the...
Clinical trials explained: Why health literacy matters…
Clinical trial recruitment can be a challenge. By applying the principles of health literacy to all materials, we can support people to make an informed choice about whether to take...
Clinical trials explained: Why iconography matters…
Icons serve as a useful form of alternative communication. We spend a lot of time developing icons for healthcare communications. Find out how we use iconography to elevate clinical trial...
Cuttsy+Cuttsy appoints Harriet Karia as Managing Director
Cuttsy+Cuttsy is pleased to announce the appointment of Harriet Karia as its first Managing Director.
Using generative AI in healthcare comms – our promise to our clients
It’s safe to say one of the hottest topics of 2023 has been ChatGPT and the launch of other Generative AI-driven applications. So, we’re sharing our promises, so that when...
Clinical trials explained: Why colour matters…
Colour can be used to emphasise mood, evoke emotions, and determine first impressions of a brand. Find how to use colour effectively in your next clinical trial campaign.
Clinical trials explained: Why branding matters…
With nearly a decade’s experience supporting clinical trials, find out why we think humanising trials through design is so important.
DPHARM2023 – Five key themes impacting clinical trials today
Throughout three fascinating days of conference, some key themes emerged that are impacting study teams and the effectiveness of their clinical trials on a daily basis.
Flexible working: a fad or the future?
As the Flexible Working Bill gets written into UK law, we took a look at what this means for businesses of all sizes and specialities.